Kadek Ida Krisnadewi, S. A. Kristina, D. Endarti, T. Andayani
{"title":"Health interventions and its impact on outcomes among diabetic patients: A systematic review","authors":"Kadek Ida Krisnadewi, S. A. Kristina, D. Endarti, T. Andayani","doi":"10.29090/psa.2022.04.22.041","DOIUrl":null,"url":null,"abstract":"primary health care, and c) work 9 . The same review by Laws R.A (2012) showed efficacy intervention by external validity and behaviors related to preventive programs. The results can generalized from external validity 10 . In this systematic review, the authors evaluate ABSTRACT Studies related to the prevention of diabetes mellitus have developed rapidly, from effectiveness research to implementation research. However, effective implementation of diabetes programs and evidence of their impact on the population should be produced by means other than measuring the effectiveness of the program. We reviewed the results of systematic reviews focused on diabetes prevention programs and the outcomes of those programs in a real-world setting. A systematic review of the program aimed at assessing or measuring the outcome of preventive programs in individual prediabetes, moderate or high-risk diabetes. In September 2021, an article search was performed on PubMed, Science Direct, and SAGE Journal databases. We have reviewed all the articles published in the last ten years. The exclusion criteria were studies published before 2011. The number of diabetic participants is unknown and the method is incomplete. Eight studies were included in the review. All information about participation and programs. Most of all studies were cohort and RCT studies. All interventions showed positive changes (efficacy) based on weight loss, HbA1C, blood glucose levels, and BMI. Rapid studies have shown that the risk of diabetes is reduced. Our results show that the strength of the program plays an important role in the outcome of weight loss. Programs with different variations (education, Community Health worker, diet, physical activity) have had a positive effect on reducing the risk of diabetes in the population.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"41 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Sciences Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29090/psa.2022.04.22.041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
primary health care, and c) work 9 . The same review by Laws R.A (2012) showed efficacy intervention by external validity and behaviors related to preventive programs. The results can generalized from external validity 10 . In this systematic review, the authors evaluate ABSTRACT Studies related to the prevention of diabetes mellitus have developed rapidly, from effectiveness research to implementation research. However, effective implementation of diabetes programs and evidence of their impact on the population should be produced by means other than measuring the effectiveness of the program. We reviewed the results of systematic reviews focused on diabetes prevention programs and the outcomes of those programs in a real-world setting. A systematic review of the program aimed at assessing or measuring the outcome of preventive programs in individual prediabetes, moderate or high-risk diabetes. In September 2021, an article search was performed on PubMed, Science Direct, and SAGE Journal databases. We have reviewed all the articles published in the last ten years. The exclusion criteria were studies published before 2011. The number of diabetic participants is unknown and the method is incomplete. Eight studies were included in the review. All information about participation and programs. Most of all studies were cohort and RCT studies. All interventions showed positive changes (efficacy) based on weight loss, HbA1C, blood glucose levels, and BMI. Rapid studies have shown that the risk of diabetes is reduced. Our results show that the strength of the program plays an important role in the outcome of weight loss. Programs with different variations (education, Community Health worker, diet, physical activity) have had a positive effect on reducing the risk of diabetes in the population.
Pharmaceutical Sciences AsiaPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
0.90
自引率
0.00%
发文量
59
期刊介绍:
The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: Clinical Pharmacy Drug Synthesis and Discovery Targeted-Drug Delivery Pharmaceutics Biopharmaceutical Sciences Phytopharmaceutical Sciences Pharmacology and Toxicology Pharmaceutical Chemistry Nutraceuticals and Functional Foods Natural Products Social, Economic, and Administrative Pharmacy Clinical Drug Evaluation and Drug Policy Making Antimicrobials, Resistance and Infection Control Pharmacokinetics and Pharmacodynamics.